Liquiritigenin Ameliorates Rheumatoid Arthritis by Modulating the Nrf2/NF-κB/NLRP3 Pathway in Fibroblast-like Synoviocytes
Zhuoxi Chen, Nana Chen, Limin Liu, Yingrui Wang, Lejian Zhu, Hui Yang, Zhuqi Han, Xiaoyu Zhang, Shuo Yan, Yuan Du, Leiming Zhang · 2026
Read Liquiritigenin Ameliorates Rheumatoid Arthritis by Modulating the Nrf2/NF-κB/NLRP3 Pathway in Fibroblast-like Synoviocytes by Zhuoxi Chen, Nana Chen, Limin Liu, Yingrui Wang, Lejian Zhu, Hui Yang, Zhuqi Han, Xiaoyu Zhang, Shuo Yan, Yuan Du, Leiming Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13210720.txt.
Description
Zhuoxi Chen and co-authors test liquiritigenin, a licorice-root flavonoid, against rheumatoid arthritis, focusing on the joint-lining cells that drive its damage. In this autoimmune disease, fibroblast-like synoviocytes overactivate, invade cartilage, and feed inflammation. The team used a rat model of arthritis and a human joint cell line inflamed in the dish.
In rats, the compound eased joint swelling and bone damage and calmed the thickened joint lining. In cells, it slowed growth, migration, and invasion, cut damaging oxygen by-products, and lowered two inflammatory messengers in both rat blood and cell fluid. Protein tests confirmed it works through a named defense-and-inflammation pathway trio. The authors propose the licorice compound as a candidate for further arthritis drug work.
Catalog record
| CREATOR | Zhuoxi Chen, Nana Chen, Limin Liu, Yingrui Wang, Lejian Zhu, Hui Yang, Zhuqi Han, Xiaoyu Zhang, Shuo Yan, Yuan Du, Leiming Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |